US5019761049 - KYTX (XNAS)
Kyverna Therapeutics, Inc. - Common Stock Share
3,89 USD
Current Prices from Kyverna Therapeutics, Inc. - Common Stock
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
NASDAQ |
KYTX
|
USD
|
24.12.2024 18:15
|
3,89 USD
| 3,92 USD | -0,77 % |
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,52 % | -7,16 % | -11,39 % | -33,45 % | -49,68 % | -87,03 % | -87,03 % |
Perfil de la empresa para Kyverna Therapeutics, Inc. - Common Stock Acción
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients suffering from autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of patients with lupus nephritis and systemic sclerosis that is in Phase I clinical trial; and for myasthenia gravis and multiple sclerosis that is in Phase II clinical trial. The company is also developing KYV-201, an allogeneic CD19 CAR T-cell product candidate that is in preclinical stage to treat multiple autoimmune diseases. In addition, it is developing product candidates to treat other autoimmune diseases, such as inflammatory bowel disease that includes Crohn's disease and ulcerative colitis. Kyverna Therapeutics, Inc. has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product; and with Kite to research and develop programs for the treatment, diagnosis, and prevention of autoimmune, inflammatory, and allogeneic stem cell transplant inflammatory diseases. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Datos de la empresa para Kyverna Therapeutics, Inc. - Common Stock Acción
Nombre Kyverna Therapeutics, Inc. - Common Stock
Empresa Kyverna Therapeutics, Inc. Common Stock
Símbolo KYTX
Sitio web https://kyvernatx.com
Mercado principal
NASDAQ
ISIN US5019761049
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Mr. Warner Biddle
Capitalización de mercado 214 Mio
Moneda USD
Empleados 0,1 T
Símbolos de cotización
Nombre | Símbolo |
---|---|
NASDAQ | KYTX |
Otras acciones
Los inversores que tienen Kyverna Therapeutics, Inc. - Common Stock también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.